RCS - GenIP PLC - GenIP to Sponsor Technology Transfer Conference

GenipAnnouncement

22/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241022:nRSV9971Ia&default-theme=true

RNS Number : 9971I  GenIP PLC  22 October 2024

 

 

 

22 October 2024

 

GenIP Plc

("GenIP" or the "Company")

 

GenIP to Sponsor the XVIII National Brazilian Forum of

Innovation and Technology Transfer Managers (FORTEC)

 

GenIP is pleased to announce its sponsorship and participation in the XVIII
National FORTEC Meeting, scheduled for November 3rd to 6th, 2024, at the
Pontifical Catholic University (PUC) of Campinas in São Paulo. This industry
event will convene over 350 professionals from 60 Technology Transfer Offices
representing Brazil's leading universities and research centers.

 

The FORTEC Meeting is a well-established platform for advancing knowledge in
Intellectual Property, Technology Transfer, and Innovation. FORTEC plays a
crucial role in fostering collaboration and knowledge-sharing among key
stakeholders in the innovation ecosystem. Situated in Campinas, a recognized
technological hub in Brazil, this event highlights the city's prominence as a
center for research and development. With its top-tier universities and
research institutions, Campinas serves as an ideal backdrop for GenIP to
showcase our cutting-edge solutions, including our new GenAI-enhanced
Invention Evaluator and Vortechs services.

 

GenIP's Commitment to Innovation

 

Eduardo Giacomazzi, GenIP's Sales Representative in Brazil, will be
representing the Company at this event and will moderate a panel on
Entrepreneurship in ICTs. He will discuss the critical role of technology
transfer in driving innovation and how GenIP can assist organisations in
navigating the complexities of bringing new technologies to market. GenIP's
dedication to leveraging generative artificial intelligence solutions empowers
clients to enhance decision-making and streamline the commercialisation
process effectively.

 

Melissa Cruz, CEO of GenIP, commented:

 

"We are excited to sponsor and participate in the XVIII National FORTEC
Meeting and to engage with industry leaders in technology transfer and
innovation. This event presents a great opportunity for GenIP to showcase our
capabilities and contribute to the positive advancements in Brazil's National
Science and Technology System."

 

 Gesil Sampaio Amarante Segundo, Ph. D., President of FORTEC, commented:

 

"We are honored to have GenIP plc as a co-sponsor of the upcoming XVIII
National Brazilian Forum of Innovation and Technology Transfer Managers
(FORTEC). GenIP's GenAI services are designed to help organizations identify
and commercialize their high value discoveries. These services can play an
important role in enhancing the efficiency of Brazil's rapidly developing
technology ecosystem."

 

Newton Frateschi, Ph. D. General Coordinator of the XVIII National FORTEC
event, commented:

 

"A central challenge for Tech Transfer Offices is to manage a broad technology
portfolio within a tangible market, and provide open innovation analysis in a
fast paced environment.  I believe GenIP has the proper tools to help in this
endeavor."

 

Recognition and Impact

 

GenIP will also present awards to acknowledge outstanding contributions to
Brazil's National Science and Technology System, demonstrating our commitment
to fostering innovation and supporting initiatives that have a meaningful
impact on the industry. We believe GenIP's engagement in this event will
bolster our brand and catalyze new business opportunities in this important
market.

 

 

For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:

 

 GenIP Plc                                    Tel: +44 (0) 20 3368 3090

 Melissa Cruz, CEO

 Redchurch Communications (Financial PR)      genip@weareredchurch.com (mailto:genip@weareredchurch.com)

 John Casey

Definitions

 

 FORTEC  Brazilian Forum of Innovation and Technology Transfer Managers
 GenAI   Generative artificial intelligence
 ICTs    Information and communication technologies

 

 

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulations would be disseminated as an RNS
regulatory announcement and not on Reach.

 

 

 

 

Notes to Editors

 

About GenIP

 

GenIP provides generative artificial intelligence (GenAI) analytic services to
help companies, research institutions and venture funds assess and
commercialise new discoveries. GenIP combines expert human technical review
with GenAI algorithms to provide insightful and verified services.

 

GenIP provides two complementary platform-based services:

1.   Invention Evaluator: Provides bespoke research reports that assess the
market potential of new technological innovations and discoveries using
AI-driven proprietary software; and

 

2.   Vortechs: which is an executive recruitment platform that through
advanced machine learning algorithms and natural language processing
technologies assists in matching technology organisations with experienced
executives skilled in technology commercialisation.

 

The Company believes that its integrated GenAI service offerings will help
organisations to evaluate and commercialise their technological innovations.

 

Company Strategy

GenIP's goal is to create a leading Generative AI analytic services company.
To achieve this, the Company has established three strategic pillars:

 

●    Organically grow InventionEvaluator and Vortechs' revenue through
institutional and corporate connections as well as increase client pipeline
through marketing, advertising and social media spend.

●    Expand the Generative AI service offerings within InventionEvaluator
and Vortechs' to reach new customers and improve margins.

●    Bolt-on acquisitions of additional Generative AI services that are
helpful to our clients and have demonstrated initial market traction.

 

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking
statements. When used in this announcement, the words "may", "would", "could",
"will", "intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to the Company,
are intended to identify forward-looking statements. These statements include,
but are not limited to, statements regarding intentions, beliefs or current
expectations concerning, among other things, the Company's results of
operations, financial position, liquidity, prospects, growth, strategies and
expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future
events and are subject to certain risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements
to materially differ from those described in this announcement Should one or
more of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual results may
differ materially from those described in this announcement as "intended",
"planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any
hyperlinks accessible from the Company's website are not incorporated by
reference into, and do not form part of, this announcement and investors
should not rely on them.

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABXBDGSXDDGSB